Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Tissue Regenix
Life Sciences
Operating leverage
By
Dr Martin Hall
27 Sep 2022
Macro issues dominate investor sentiment
By
Keith Hiscock
23 Sep 2022
Oakley Capital Investments
Investment Companies
1H’22: results prove NAV real, resilient and growing
By
Mark Thomas
20 Sep 2022
Volta Finance
Investment Companies
Cash is king and the king is rocking and rolling
By
Mark Thomas
16 Sep 2022
Shield Therapeutics Plc
Life Sciences
Accrufer momentum building
By
Dr Martin Hall
15 Sep 2022
Chesnara Plc
Financials
Robust cash generation in challenging markets
By
Dr Brian Moretta
12 Sep 2022
Neodecortech
Consumer
Bright 1H’22, cloudy outlook
By
Jason Streets
12 Sep 2022
Surface Transforms
Industrial
Further new order, upgrades, production ramp-up
By
Mike Foster
06 Sep 2022
Fidelity China Special Situations Plc
Investment Companies
The Peking duck is not burning to a crisp
By
Mark Thomas
05 Sep 2022
The Monthly: September 2022
01 Sep 2022
Praetura Ventures Ltd
Financials
Praetura EIS Growth Fund
By
Dr Brian Moretta
15 Aug 2022
Prev
1
...
18
19
20
21
22
...
84
Next
